TARPLIN, DOWNS & YOUNG, LLC for BIOTECHNOLOGY INDUSTRY ORGANIZATION
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report | Apr 18, 2014 | $80,000 | Replaced |
| 1st Quarter - Amendment (this page) | Dec 23, 2016 | $80,000 | Replaced |
| 1st Quarter - Amendment | Jan 5, 2017 | $80,000 | Yes |
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
budget resolution, reconciliation, deficit reduction, debt ceiling H.R. 3547, the Consolidated Appropriations Act, 2014
| Lobbyist | Covered position, as disclosed |
|---|---|
| RAISSA H DOWNS | Prin. Dep. Asst. Sec. for Leg. - HHS; Dep. Asst. Prin. Dep. Asst. Sec. for Leg. - HHS; Dep. Asst. Employment, Sen. HELP Cmte. |
| MICHELLE P EASTON | Chief Health Counsel, Sen. Cmte. On Finance; Staff Dir., Senate Aging Cmte.; Leg. Asst. Congressman Billy Tauzin |
| LINDA E TARPLIN | Sp. Asst. to the Pres. for Leg. Affairs; Dep. Asst. Sec. for Leg. - HHS |
| JENNIFER B YOUNG | Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg. - HHS; Cmte. Staff, House Cmte. on Ways and Means; Cmte. Staff, Sen. Cmte. on Finance |
Taxation/Internal Revenue Code TAX
PL 111-148 - The Patient Protection and Affordable Care Act, PL 111-152 - The Reconciliation Act of 2010, implementation, pharmaceutical tax, therapeautic tax credit Expiring Provisions Improvement Reform and Efficiency (EXPIRE) Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| RAISSA H DOWNS | — |
| MICHELLE P EASTON | — |
| LINDA E TARPLIN | — |
| JENNIFER B YOUNG | — |
Health Issues HCR
PL 111-148 - The Patient Protection and Affordable Care Act, PL 111-152 - The Reconciliation Act of 2010, implementation, biosimilars, 340B, disclosure, comparative effectiveness research H.R. 2725, S. 1413 - Safety Over Sequester Act, user fee sequester relief ***, no specific bill(s), health care reform, Biosimilars, PDUFA and related FDA policies
| Lobbyist | Covered position, as disclosed |
|---|---|
| RAISSA H DOWNS | — |
| MICHELLE P EASTON | — |
| LINDA E TARPLIN | — |
| JENNIFER B YOUNG | — |
Medicare/Medicaid MMM
Medicare and Medicaid Drug Reimbursement, Medicaid Rebate, Medicare Part D Non-Interference, health care reform, drug implementation, biosimilars, 340B, Sunshine, discount cards PL 111-148 - The Patient Protection and Affordable Care Act, PL 111-152 - The Reconciliation Act of 2010, implementation H.R. 351/S. 351 - Protecting Seniors' Access to Medicare Act of 2013 H.R. 2810 - Medicare Patient Access and Quality Improvement Act of 2013, SGR S. 1871 - SGR Repeal and Medicare Beneficiary Access Act of 2013 H.R. 4302 - Protecting Access to Medicare Act of 2014
| Lobbyist | Covered position, as disclosed |
|---|---|
| RAISSA H DOWNS | — |
| MICHELLE P EASTON | — |
| LINDA E TARPLIN | — |
| JENNIFER B YOUNG | — |
Pharmacy PHA
PL 112-144 - The Food and Drug Administration Safety and Innovation Act, implementation H.R. 2186 - Valid Compounding Act H.R. 3204 - The Drug Quality and Security Act, implementation H.R. 2725, S. 1413 - Safety Over Sequester Act, user fee sequester relief ***, no specific bill(s), Drug Safety, Prescription Drug Importation, Import Safety, supply chain integrity, biosimilars, PDUFA and associated policies, patent settlements, accelerated approval, break through therapies, compounding, user fee sequester
| Lobbyist | Covered position, as disclosed |
|---|---|
| RAISSA H DOWNS | — |
| MICHELLE P EASTON | — |
| LINDA E TARPLIN | — |
| JENNIFER B YOUNG | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.